Strides Pharma Science receives 5 USFDA observations after Bengaluru facility inspection
Drug firm Strides Pharma Science Ltd on Wednesday (May 20) said the United States Food and Drug Administration (USFDA) has completed a routine current Good Manufacturing Practices (cGMP) inspection at the company’s flagship facility in Bengaluru. The inspection was conducted from May 12, 2026, to May 20, 2026. At the conclusion of the inspection, the…
